Enter inventor name

Average Co-Inventor Count = 15.4

ph-index = 8

Forward Citations = 233(Granted Patents)

Location History:

Chesterfield, MI (US) (2004)
Maryland Heights, MO (US) (2006 - 2009)
Chesterfield, MO (US) (2002 - 2010)
Albany, GA (US) (2013 - 2014)

Company Filing History:

17 out of 200

Pharmacia Corporation

patents

12 out of 1,323

G.d. Searle & Company

Pharmacia Corporation Global Patent Department

patent

Years Active: 2002-2014

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8633206 - Pyrrolo[2,3-D]pyrimidine compounds (2014-01-21),

2. 8372854 - Pyrrolo[2,3-D]pyrimidine compounds (2013-02-12),

3. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),

4. 7629363 - Diaryl substituted pyridinones (2009-12-08),

5. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),

6. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),

7. 7067540 - Substituted pyridinones (2006-06-27),

8. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

9. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),

10. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

11. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

12. 6710089 - Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-23),

13. 6699898 - Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-02),

14. 6696472 - Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

15. 6696435 - Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

Title: The Innovative Journey of Michele A. Promo in Chesterfield, MO

Introduction

Michele A. Promo, based in Chesterfield, MO, is a prominent inventor with an impressive portfolio of 38 patents. His work primarily revolves around groundbreaking compounds and their applications in the pharmaceutical industry, highlighting his significant contributions to medical science.

Latest Patents

Among his most recent patents are various pyrrolo[2,3-d]pyrimidine compounds. These compounds are noteworthy for their function as Janus Kinase (JAK) inhibitors. The patents detail not only the compounds themselves but also their pharmaceutical compositions and methods for their preparation, showcasing Michele's commitment to advancing therapeutic options.

Career Highlights

Michele's career includes valuable experiences at renowned companies such as Pharmacia Corporation and G.D. Searle & Company. His time in these organizations allowed him to enhance his skills and contribute to the development of innovative pharmaceutical products, further establishing his reputation as a skilled inventor.

Collaborations

Throughout his career, Michele has collaborated with notable professionals, including Richard C. Durley and Brian S. Hickory. These collaborations have likely enriched his work, allowing for the exchange of ideas and the integration of diverse expertise in the field of pharmaceutical invention.

Conclusion

Michele A. Promo stands out as a prolific inventor whose work has significantly impacted the realm of medicinal chemistry. With 38 patents to his name and continuous advancements in JAK inhibitors, Michele's contributions are invaluable, paving the way for future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

For the Inventor, By the Inventor

Michele A Promo

Location History:

Company Filing History:

Years Active: 2002-2014